These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32192399)

  • 1. Successful treatment of refractory lupus erythematosus profundus with the interleukin-6 antagonist tocilizumab: a case report.
    Elolemy G; Al Rashidi A; Dehrab A; Almathkouri A; Varghese A; Chikhly M; Alkhawaja F
    Lupus; 2020 Jun; 29(7):791-794. PubMed ID: 32192399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized lupus erythematosus profundus in a patient with genetic partial deficiency of C4.
    Nousari HC; Kimyai-Asadi A; Provost TT
    J Am Acad Dermatol; 1999 Aug; 41(2 Pt 2):362-4. PubMed ID: 10426934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab for the treatment of lupus erythematosus panniculitis.
    Moreno-Suárez F; Pulpillo-Ruiz A
    Dermatol Ther; 2013; 26(5):415-8. PubMed ID: 24099073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging findings are useful for evaluating the three-dimensional development and follow-up of linear lupus erythematosus profundus.
    Ogawa M; Muro Y; Sugiura K; Sakakibara A; Akiyama M
    Lupus; 2015 Oct; 24(11):1214-6. PubMed ID: 25716419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of "refractory" lupus erythematosus profundus responsive to rituximab [case report].
    McArdle A; Baker JF
    Clin Rheumatol; 2009 Jun; 28(6):745-6. PubMed ID: 19343472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus profundus (panniculitis): a potential mimic of subcutaneous panniculitis-like T-cell lymphoma.
    Arps DP; Patel RM
    Arch Pathol Lab Med; 2013 Sep; 137(9):1211-5. PubMed ID: 23991732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ANCA-positive lupus erythematodes profundus. Successful therapy with low dosage dapsone].
    Böhm I; Bruns A; Schupp G; Bauer R
    Hautarzt; 1998 May; 49(5):403-7. PubMed ID: 9642563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lupus erythematosus panniculitis: clinical and histopathological analysis of 22 cases].
    Wang T; Li X; Liu YH; Zheng HY; Sun QN; Jin HZ; Ma DL; Qu T; Fang K
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):525-8. PubMed ID: 22338136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kaposi-Irgang lupus erythematosus profundus. Lupus erythematosus panniculitis].
    Süss R; Meurer M; Schirren CG; Lübke S; Ruzicka T
    Hautarzt; 1994 Jan; 45(1):38-41. PubMed ID: 8150615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Immunoglobulin in the Management of Lupus Erythematosus Panniculitis.
    AlQadri NG; AlNooh B; AlTewerki MM; Almotairi A; Alajlan S
    Cureus; 2020 Jan; 12(1):e6790. PubMed ID: 32025447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful use of interleukin 6 antagonist tocilizumab in a patient with refractory cutaneous lupus and urticarial vasculitis.
    Makol A; Gibson LE; Michet CJ
    J Clin Rheumatol; 2012 Mar; 18(2):92-5. PubMed ID: 22334272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cutaneous lupus profundus].
    Khalfallah N; Azzabi S; Ben Hassine L; Fathallah L; Kooli C; Fazâa B; Hamza M; Haddad A
    Tunis Med; 2003 Feb; 81(2):134-9. PubMed ID: 12708181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus erythematosus panniculitis in a patient with autoimmune hepatitis.
    Fujiwara K; Kono T; Ishii M; Taniguchi S; Saito S
    Acta Derm Venereol; 2000; 80(5):373-5. PubMed ID: 11200838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin in the management of refractory lupus profundus.
    Namas R; Abdulla FA; Elarabi M
    Lupus; 2022 Jul; 31(8):1012-1016. PubMed ID: 35561340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proportion of lymphocytic inflammation with CD123-positive cells in lupus erythematous profundus predict a clinical response to treatment.
    Miyashita A; Fukushima S; Makino T; Yoshino Y; Yamashita J; Honda N; Aoi J; Ichihara A; Jinnin M; Inoue Y; Ihn H
    Acta Derm Venereol; 2014 Sep; 94(5):563-7. PubMed ID: 24352508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus erythematosus profundus--report of a case treated with dapsone.
    Yamada Y; Dekio S; Jidoi J; Ozasa S
    J Dermatol; 1989 Oct; 16(5):379-82. PubMed ID: 2600276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facets of lupus erythematosus: panniculitis responding to thalidomide.
    Wienert S; Gadola S; Hunziker T
    J Dtsch Dermatol Ges; 2008 Mar; 6(3):214-6. PubMed ID: 18076656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus profundus, indeterminate lymphocytic lobular panniculitis and subcutaneous T-cell lymphoma: a spectrum of subcuticular T-cell lymphoid dyscrasia.
    Magro CM; Crowson AN; Kovatich AJ; Burns F
    J Cutan Pathol; 2001 May; 28(5):235-47. PubMed ID: 11401667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linear lupus erythematosus profundus as an initial manifestation of systemic lupus erythematosus in a child.
    Fernandes S; Santos S; Freitas I; Salgado M; Afonso A; Cardoso J
    Pediatr Dermatol; 2014; 31(3):378-80. PubMed ID: 23253093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintaining remission of lupus erythematosus profundus (LEP) with cyclosporin A.
    Saeki Y; Ohshima S; Kurimoto I; Miura H; Suemura M
    Lupus; 2000; 9(5):390-2. PubMed ID: 10878735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.